Revium Rx. Share Price

Stocks

Market Closed - OTC Markets Other stock markets 07:00:09 30/03/2026 pm IST			5-day change	1st Jan Change
1.670 ^USD	+11.33%		-.--%	+221.15%

22/06	Revium Rx. Announces Resignation of Inna Martin from Director, Chief Operating Officer and President, Effective June 16, 2026	CI
01/06	Revium Rx. Announces CFO Changes, Effective May 27, 2026	CI

Market Cap	10Cr 8.91Cr 8.28Cr 7.6Cr 14Cr 976.66Cr 15Cr 98Cr 38Cr 480.16Cr 38Cr 37Cr 1.66TCr	P/E 2024	-11.7x	P/E 2025	-2.35x
Enterprise Value	9.88Cr 8.68Cr 8.07Cr 7.41Cr 14Cr 951.54Cr 14Cr 96Cr 37Cr 467.81Cr 37Cr 36Cr 1.62TCr	EV / Sales 2024	-	EV / Sales 2025	-
Free-Float	-	Yield 2024 *	-	Yield 2025	-

22/06	Revium Rx. Announces Resignation of Inna Martin from Director, Chief Operating Officer and President, Effective June 16, 2026	CI
01/06	Revium Rx. Announces CFO Changes, Effective May 27, 2026	CI
15/05	Revium Rx. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
21/04	Revium Rx. Appoints Amir Avraham as Permanent Chief Executive Officer, Effective as of February 1, 2026	CI
21/04	Revium Rx. Appoints Shlomi Schwartzblat as Director and Chairman of the Board, Effective April 14, 2026	CI
01/04	Revium Rx. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
31/03	Revium Rx. Auditor Raises 'Going Concern' Doubt	CI
17/01	Revium Rx. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
21/25/21	Revium Recovery Inc. Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections	CI
04/25/04	Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
14/25/14	Revium Rx. has filed an IPO in the amount of $5 million.	CI
04/25/04	Revium Recovery Inc. completed the acquisition of LipoVac, Ltd.	CI
20/22/20	Revium Recovery Inc. entered into a letter of intent to acquire LipoVac, Ltd.	CI

21/25/21	Revium Rx Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections	GL
05/25/05	Revium Rx (RVRC) Completes Acquisition of LipoVation Ltd.	GL
21/22/21	Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd	AQ
20/22/20	Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd.	AQ
18/20/18	Correction: REVIUM RECOVERY ACQUIRES ANTI-ADDICTION REHABILITATION BUSINESS	GL

Manager	Title	Age	Since
Amir Avraham CEO	Chief Executive Officer	-	22/05/2025
Igor Bluvstein DFI	Director of Finance/CFO	46	27/05/2026
Inna Martin CEO	Chief Executive Officer	51	-

Director	Title	Age	Since
Inna Martin BRD	Director/Board Member	51	-
Matti Munk BRD	Director/Board Member	-	-
Yoram Druker BRD	Director/Board Member	-	-

	2024	2025
Net sales	-	-
Net income	-35.05L -30.78L -28.63L -26.27L -49.36L -34Cr -50.12L -3.4Cr -1.33Cr -17Cr -1.32Cr -1.29Cr -57Cr	-1.34Cr -1.18Cr -1.1Cr -1.01Cr -1.89Cr -129.52Cr -1.92Cr -13Cr -5.1Cr -64Cr -5.05Cr -4.94Cr -220.15Cr
Net Debt	-52.78L -46.36L -43.11L -39.56L -74.33L -51Cr -75.48L -5.12Cr -2Cr -25Cr -1.98Cr -1.94Cr -86Cr	-26.09L -22.91L -21.31L -19.55L -36.74L -25Cr -37.31L -2.53Cr -98.87L -12Cr -97.94L -95.83L -43Cr

Employees

Sector